IS Pharma goes for growth
by Real Deals - Friday, 2nd May 2008
This is the page
Bank of Scotland Corporate is to provide AIM-listed IS Pharma with a facility worth £8m (€10m) to fund the company’s continued growth and acquisition plans. IS Pharma is a late-stage pharmaceuticals and medical devices business in the specialist hospital medicine sector, with a current focus on critical care, neurology and oncology. The Chester-based company recently acquired Swiss pharmaceuticals group, Speciality European Pharmaceuticals, for £9.25m. IS Pharma, previously Maelor, adopted its new name following the acquisition, which has given it a new portfolio of specialist hospital pharmaceutical products.
Tags: aim, growth, private equity, raising finance, medical, is pharma,
BUSINESS NEWS >>
By Real Business - December 04, 2008 4:54pm GMT
By Martin Dunne - December 04, 2008 2:00pm GMT
By Catherine Woods - December 04, 2008 1:44pm GMT
By Rebecca Burn-Callander - December 04, 2008 1:38pm GMT
By Catherine Woods - December 04, 2008 12:14pm GMT
BUSINESS COMMENT >>
By Catherine Woods - December 04, 2008 11:10am GMT
By Rebecca Burn-Callander - December 04, 2008 11:10am GMT
By Catherine Woods - December 04, 2008 10:52am GMT
By Rebecca Burn-Callander - December 02, 2008 11:18am GMT
By Rebecca Burn-Callander - December 01, 2008 1:01pm GMT








